行情

SLDB

SLDB

SOLID BIOSCIENCE
NASDAQ

实时行情|Nasdaq Last Sale

10.50
+0.36
+3.55%
盘后: 10.50 0 0.00% 16:00 09/16 EDT
开盘
10.13
昨收
10.14
最高
10.65
最低
10.00
成交量
30.52万
成交额
--
52周最高
54.54
52周最低
4.320
市值
4.83亿
市盈率(TTM)
-3.7564
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SLDB 新闻

  • 沪指震荡微跌 沙特石油设施遇袭、油价一度跳升20%
  • 新浪财经.13小时前
  • 消息称美国或将承诺不对日本汽车加税
  • 新浪财经.14小时前
  • 美国通用汽车近5万工人开始罢工 或造成数亿美元损失
  • 新京报网.15小时前
  • 渣打发现多位私人银行大客财富来历不明
  • 新浪财经.15小时前

更多

所属板块

生物技术和医学研究
+0.91%
制药与医学研究
-0.17%

热门股票

名称
价格
涨跌幅

SLDB 简况

Solid Biosciences Inc., formerly Solid Biosciences, LLC, is a life science company. The Company is focused on developing therapies for duchenne muscular dystrophy (DMD). It is developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its corrective therapies platform is engaged in the development of gene therapy candidates for DMD. Its lead program, SGT-001, is an adeno-associated virus (AAV) microdystrophin gene therapy candidate, which focuses on enabling the systemic delivery of a shortened yet functional version of the dystrophin gene. The Company is examining small molecule and biologic candidates that may help manage the secondary disorders associated with DMD. It is developing Wearable support for patients with DMD. The hardware of its assistive devices is composed of three technologies: force generating actuators (or motors), electrically controlled clutches, and harness technology called Flex Grip.
展开

Webull提供Solid Biosciences Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。